{"GPL7567": [{"GSM339820": [{"title": "Trial1 Subject ID 1901 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1901_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  7.68;\tNeuralizing Antibody Titer: 320;\tTime: 0;\tTrial: 1"}]}, {"GSM339821": [{"title": "Trial1 Subject ID 1901 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1901_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  7.68;\tNeuralizing Antibody Titer: 320;\tTime: 3;\tTrial: 1"}]}, {"GSM339822": [{"title": "Trial1 Subject ID 1901 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1901_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  7.68;\tNeuralizing Antibody Titer: 320;\tTime: 7;\tTrial: 1"}]}, {"GSM339823": [{"title": "Trial1 Subject ID 1902 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1902_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  12.1;\tNeuralizing Antibody Titer: 200;\tTime: 0;\tTrial: 1"}]}, {"GSM339824": [{"title": "Trial1 Subject ID 1902 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1902_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  12.1;\tNeuralizing Antibody Titer: 200;\tTime: 3;\tTrial: 1"}]}, {"GSM339825": [{"title": "Trial1 Subject ID 1902 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1902_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  12.1;\tNeuralizing Antibody Titer: 200;\tTime: 7;\tTrial: 1"}]}, {"GSM339826": [{"title": "Trial1 Subject ID 1903 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1903_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.8;\tNeuralizing Antibody Titer: 80;\tTime: 0;\tTrial: 1"}]}, {"GSM339827": [{"title": "Trial1 Subject ID 1903 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1903_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.8;\tNeuralizing Antibody Titer: 80;\tTime: 3;\tTrial: 1"}]}, {"GSM339828": [{"title": "Trial1 Subject ID 1903 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1903_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.8;\tNeuralizing Antibody Titer: 80;\tTime: 7;\tTrial: 1"}]}, {"GSM339829": [{"title": "Trial1 Subject ID 1904 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1904_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.56;\tNeuralizing Antibody Titer: 60;\tTime: 0;\tTrial: 1"}]}, {"GSM339830": [{"title": "Trial1 Subject ID 1904 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1904_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.56;\tNeuralizing Antibody Titer: 60;\tTime: 3;\tTrial: 1"}]}, {"GSM339831": [{"title": "Trial1 Subject ID 1904 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1904_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.56;\tNeuralizing Antibody Titer: 60;\tTime: 7;\tTrial: 1"}]}, {"GSM339832": [{"title": "Trial1 Subject ID 1906 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1906_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.5;\tNeuralizing Antibody Titer: 160;\tTime: 0;\tTrial: 1"}]}, {"GSM339833": [{"title": "Trial1 Subject ID 1906 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1906_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.5;\tNeuralizing Antibody Titer: 160;\tTime: 3;\tTrial: 1"}]}, {"GSM339834": [{"title": "Trial1 Subject ID 1906 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1906_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  11.5;\tNeuralizing Antibody Titer: 160;\tTime: 7;\tTrial: 1"}]}, {"GSM339835": [{"title": "Trial1 Subject ID 1907 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1907_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.74;\tNeuralizing Antibody Titer: 20;\tTime: 0;\tTrial: 1"}]}, {"GSM339836": [{"title": "Trial1 Subject ID 1907 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1907_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.74;\tNeuralizing Antibody Titer: 20;\tTime: 3;\tTrial: 1"}]}, {"GSM339837": [{"title": "Trial1 Subject ID 1907 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1907_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.74;\tNeuralizing Antibody Titer: 20;\tTime: 7;\tTrial: 1"}]}, {"GSM339838": [{"title": "Trial1 Subject ID 1908 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1908_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.89;\tNeuralizing Antibody Titer: 160;\tTime: 0;\tTrial: 1"}]}, {"GSM339839": [{"title": "Trial1 Subject ID 1908 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1908_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.89;\tNeuralizing Antibody Titer: 160;\tTime: 1;\tTrial: 1"}]}, {"GSM339840": [{"title": "Trial1 Subject ID 1908 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1908_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.89;\tNeuralizing Antibody Titer: 160;\tTime: 3;\tTrial: 1"}]}, {"GSM339841": [{"title": "Trial1 Subject ID 1908 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1908_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.89;\tNeuralizing Antibody Titer: 160;\tTime: 7;\tTrial: 1"}]}, {"GSM339842": [{"title": "Trial1 Subject ID 1908 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1908_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.89;\tNeuralizing Antibody Titer: 160;\tTime: 21;\tTrial: 1"}]}, {"GSM339843": [{"title": "Trial1 Subject ID 1909 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1909_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.46;\tNeuralizing Antibody Titer: 213;\tTime: 0;\tTrial: 1"}]}, {"GSM339844": [{"title": "Trial1 Subject ID 1909 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1909_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.46;\tNeuralizing Antibody Titer: 213;\tTime: 1;\tTrial: 1"}]}, {"GSM339845": [{"title": "Trial1 Subject ID 1909 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1909_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.46;\tNeuralizing Antibody Titer: 213;\tTime: 3;\tTrial: 1"}]}, {"GSM339846": [{"title": "Trial1 Subject ID 1909 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1909_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.46;\tNeuralizing Antibody Titer: 213;\tTime: 7;\tTrial: 1"}]}, {"GSM339847": [{"title": "Trial1 Subject ID 1909 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1909_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.46;\tNeuralizing Antibody Titer: 213;\tTime: 21;\tTrial: 1"}]}, {"GSM339848": [{"title": "Trial1 Subject ID 1910 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1910_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.81;\tNeuralizing Antibody Titer: 267;\tTime: 0;\tTrial: 1"}]}, {"GSM339849": [{"title": "Trial1 Subject ID 1910 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1910_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.81;\tNeuralizing Antibody Titer: 267;\tTime: 1;\tTrial: 1"}]}, {"GSM339850": [{"title": "Trial1 Subject ID 1910 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1910_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.81;\tNeuralizing Antibody Titer: 267;\tTime: 3;\tTrial: 1"}]}, {"GSM339851": [{"title": "Trial1 Subject ID 1910 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1910_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.81;\tNeuralizing Antibody Titer: 267;\tTime: 7;\tTrial: 1"}]}, {"GSM339852": [{"title": "Trial1 Subject ID 1910 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1910_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.81;\tNeuralizing Antibody Titer: 267;\tTime: 21;\tTrial: 1"}]}, {"GSM339853": [{"title": "Trial1 Subject ID 1911 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1911_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.49;\tNeuralizing Antibody Titer: 320;\tTime: 0;\tTrial: 1"}]}, {"GSM339854": [{"title": "Trial1 Subject ID 1911 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1911_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.49;\tNeuralizing Antibody Titer: 320;\tTime: 1;\tTrial: 1"}]}, {"GSM339855": [{"title": "Trial1 Subject ID 1911 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1911_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.49;\tNeuralizing Antibody Titer: 320;\tTime: 3;\tTrial: 1"}]}, {"GSM339856": [{"title": "Trial1 Subject ID 1911 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1911_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.49;\tNeuralizing Antibody Titer: 320;\tTime: 7;\tTrial: 1"}]}, {"GSM339857": [{"title": "Trial1 Subject ID 1911 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1911_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  0.49;\tNeuralizing Antibody Titer: 320;\tTime: 21;\tTrial: 1"}]}, {"GSM339858": [{"title": "Trial1 Subject ID 1912 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1912_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.55;\tNeuralizing Antibody Titer: 80;\tTime: 0;\tTrial: 1"}]}, {"GSM339859": [{"title": "Trial1 Subject ID 1912 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1912_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.55;\tNeuralizing Antibody Titer: 80;\tTime: 1;\tTrial: 1"}]}, {"GSM339860": [{"title": "Trial1 Subject ID 1912 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1912_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.55;\tNeuralizing Antibody Titer: 80;\tTime: 3;\tTrial: 1"}]}, {"GSM339861": [{"title": "Trial1 Subject ID 1912 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1912_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.55;\tNeuralizing Antibody Titer: 80;\tTime: 7;\tTrial: 1"}]}, {"GSM339862": [{"title": "Trial1 Subject ID 1912 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1912_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.55;\tNeuralizing Antibody Titer: 80;\tTime: 21;\tTrial: 1"}]}, {"GSM339863": [{"title": "Trial1 Subject ID 1913 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1913_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.78;\tNeuralizing Antibody Titer: 53;\tTime: 0;\tTrial: 1"}]}, {"GSM339864": [{"title": "Trial1 Subject ID 1913 Day 1"}, {"type": "RNA"}, {"source_name_ch1": "T1_1913_Day_1"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.78;\tNeuralizing Antibody Titer: 53;\tTime: 1;\tTrial: 1"}]}, {"GSM339865": [{"title": "Trial1 Subject ID 1913 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1913_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.78;\tNeuralizing Antibody Titer: 53;\tTime: 3;\tTrial: 1"}]}, {"GSM339866": [{"title": "Trial1 Subject ID 1913 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1913_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.78;\tNeuralizing Antibody Titer: 53;\tTime: 7;\tTrial: 1"}]}, {"GSM339867": [{"title": "Trial1 Subject ID 1913 Day 21"}, {"type": "RNA"}, {"source_name_ch1": "T1_1913_Day_21"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.78;\tNeuralizing Antibody Titer: 53;\tTime: 21;\tTrial: 1"}]}, {"GSM339868": [{"title": "Trial1 Subject ID 1914 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1914_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.98;\tNeuralizing Antibody Titer: 80;\tTime: 0;\tTrial: 1"}]}, {"GSM339869": [{"title": "Trial1 Subject ID 1914 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1914_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.98;\tNeuralizing Antibody Titer: 80;\tTime: 3;\tTrial: 1"}]}, {"GSM339870": [{"title": "Trial1 Subject ID 1914 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1914_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.98;\tNeuralizing Antibody Titer: 80;\tTime: 7;\tTrial: 1"}]}, {"GSM339871": [{"title": "Trial1 Subject ID 1915 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1915_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.92;\tNeuralizing Antibody Titer: 320;\tTime: 0;\tTrial: 1"}]}, {"GSM339872": [{"title": "Trial1 Subject ID 1915 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1915_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.92;\tNeuralizing Antibody Titer: 320;\tTime: 3;\tTrial: 1"}]}, {"GSM339873": [{"title": "Trial1 Subject ID 1915 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1915_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.92;\tNeuralizing Antibody Titer: 320;\tTime: 7;\tTrial: 1"}]}, {"GSM339874": [{"title": "Trial1 Subject ID 1916 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T1_1916_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.99;\tNeuralizing Antibody Titer: 160;\tTime: 0;\tTrial: 1"}]}, {"GSM339875": [{"title": "Trial1 Subject ID 1916 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T1_1916_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.99;\tNeuralizing Antibody Titer: 160;\tTime: 3;\tTrial: 1"}]}, {"GSM339876": [{"title": "Trial1 Subject ID 1916 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T1_1916_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  3.99;\tNeuralizing Antibody Titer: 160;\tTime: 7;\tTrial: 1"}]}, {"GSM339877": [{"title": "Trial2 Subject ID B02 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_B02_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.12;\tNeuralizing Antibody Titer: 160;\tTime: 0;\tTrial: 2"}]}, {"GSM339878": [{"title": "Trial2 Subject ID B02 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_B02_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.12;\tNeuralizing Antibody Titer: 160;\tTime: 3;\tTrial: 2"}]}, {"GSM339879": [{"title": "Trial2 Subject ID B02 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_B02_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  6.12;\tNeuralizing Antibody Titer: 160;\tTime: 7;\tTrial: 2"}]}, {"GSM339880": [{"title": "Trial2 Subject ID B03 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_B03_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.99;\tNeuralizing Antibody Titer: 1280;\tTime: 0;\tTrial: 2"}]}, {"GSM339881": [{"title": "Trial2 Subject ID B03 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_B03_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.99;\tNeuralizing Antibody Titer: 1280;\tTime: 3;\tTrial: 2"}]}, {"GSM339882": [{"title": "Trial2 Subject ID B03 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_B03_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.99;\tNeuralizing Antibody Titer: 1280;\tTime: 7;\tTrial: 2"}]}, {"GSM339883": [{"title": "Trial2 Subject ID B08 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_B08_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.44;\tNeuralizing Antibody Titer: 1280;\tTime: 0;\tTrial: 2"}]}, {"GSM339884": [{"title": "Trial2 Subject ID B08 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_B08_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.44;\tNeuralizing Antibody Titer: 1280;\tTime: 3;\tTrial: 2"}]}, {"GSM339885": [{"title": "Trial2 Subject ID B08 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_B08_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.44;\tNeuralizing Antibody Titer: 1280;\tTime: 7;\tTrial: 2"}]}, {"GSM339886": [{"title": "Trial2 Subject ID B09 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_B09_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  5.21;\tNeuralizing Antibody Titer: 640;\tTime: 0;\tTrial: 2"}]}, {"GSM339887": [{"title": "Trial2 Subject ID B09 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_B09_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  5.21;\tNeuralizing Antibody Titer: 640;\tTime: 3;\tTrial: 2"}]}, {"GSM339888": [{"title": "Trial2 Subject ID B09 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_B09_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  5.21;\tNeuralizing Antibody Titer: 640;\tTime: 7;\tTrial: 2"}]}, {"GSM339889": [{"title": "Trial2 Subject ID D03 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_D03_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.48;\tNeuralizing Antibody Titer: 320;\tTime: 0;\tTrial: 2"}]}, {"GSM339890": [{"title": "Trial2 Subject ID D03 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_D03_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.48;\tNeuralizing Antibody Titer: 320;\tTime: 3;\tTrial: 2"}]}, {"GSM339891": [{"title": "Trial2 Subject ID D03 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_D03_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.48;\tNeuralizing Antibody Titer: 320;\tTime: 7;\tTrial: 2"}]}, {"GSM339892": [{"title": "Trial2 Subject ID E04 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_E04_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  4.88;\tNeuralizing Antibody Titer: 1280;\tTime: 0;\tTrial: 2"}]}, {"GSM339893": [{"title": "Trial2 Subject ID E04 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_E04_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  4.88;\tNeuralizing Antibody Titer: 1280;\tTime: 3;\tTrial: 2"}]}, {"GSM339894": [{"title": "Trial2 Subject ID E04 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_E04_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  4.88;\tNeuralizing Antibody Titer: 1280;\tTime: 7;\tTrial: 2"}]}, {"GSM339895": [{"title": "Trial2 Subject ID E08 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_E08_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.74;\tNeuralizing Antibody Titer: 640;\tTime: 0;\tTrial: 2"}]}, {"GSM339896": [{"title": "Trial2 Subject ID E08 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_E08_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.74;\tNeuralizing Antibody Titer: 640;\tTime: 3;\tTrial: 2"}]}, {"GSM339897": [{"title": "Trial2 Subject ID E08 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_E08_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  9.74;\tNeuralizing Antibody Titer: 640;\tTime: 7;\tTrial: 2"}]}, {"GSM339898": [{"title": "Trial2 Subject ID E09 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_E09_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.36;\tNeuralizing Antibody Titer: 160;\tTime: 0;\tTrial: 2"}]}, {"GSM339899": [{"title": "Trial2 Subject ID E09 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_E09_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.36;\tNeuralizing Antibody Titer: 160;\tTime: 3;\tTrial: 2"}]}, {"GSM339900": [{"title": "Trial2 Subject ID E09 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_E09_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  2.36;\tNeuralizing Antibody Titer: 160;\tTime: 7;\tTrial: 2"}]}, {"GSM339901": [{"title": "Trial2 Subject ID G01 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_G01_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.51;\tNeuralizing Antibody Titer: 640;\tTime: 0;\tTrial: 2"}]}, {"GSM339902": [{"title": "Trial2 Subject ID G01 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_G01_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.51;\tNeuralizing Antibody Titer: 640;\tTime: 3;\tTrial: 2"}]}, {"GSM339903": [{"title": "Trial2 Subject ID G01 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_G01_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  1.51;\tNeuralizing Antibody Titer: 640;\tTime: 7;\tTrial: 2"}]}, {"GSM339904": [{"title": "Trial2 Subject ID G03 Day 0"}, {"type": "RNA"}, {"source_name_ch1": "T2_G03_Day_0"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.47;\tNeuralizing Antibody Titer: 1280;\tTime: 0;\tTrial: 2"}]}, {"GSM339905": [{"title": "Trial2 Subject ID G03 Day 3"}, {"type": "RNA"}, {"source_name_ch1": "T2_G03_Day_3"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.47;\tNeuralizing Antibody Titer: 1280;\tTime: 3;\tTrial: 2"}]}, {"GSM339906": [{"title": "Trial2 Subject ID G03 Day 7"}, {"type": "RNA"}, {"source_name_ch1": "T2_G03_Day_7"}, {"characteristics_ch1": "PBMC;\tT Cell Activation:  8.47;\tNeuralizing Antibody Titer: 1280;\tTime: 7;\tTrial: 2"}]}]}